This week's biggest % winners & losers : May 27 - 31, 19 (wk 22)

The following are this week's top percentage gainers and losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top % gainers

• Healthcare: TBIO (10.48 +13.91%), CARA (20.56 +13.91%), VEEV (154.29 +10.69%)
• Materials: EGO (3.72 +19.61%), SBGL (3.87 +19.08%), GFI (4.46 +14.95%), AU (13.29 +14.37%)
• Industrials: HEI (121.59 +16.79%), AZUL (29.77 +12.85%), GOL (13.72 +11.82%)
• Consumer Discretionary: SEAS (32 +17.43%)
• Information Technology: PLAN (43.51 +17.25%), HIMX (3.37 +16.61%), CY (17.82 +15.19%), SMI (5.96 +13.74%), JKS (20.11 +10.74%)
• Utilities: CIG (3.74 +12.65%), SBS (11.23 +11.74%), ELP (12.14 +10.56%)

This week's top % losers

• Healthcare: KZR (9.47 -43.93%), INO (2.39 -26.69%), EVH (10.64 -24.81%), OMI (2.69 -22.7%), TEVA (8.65 -20.42%)
• Industrials: PBI (3.65 -21.17%)
• Consumer Discretionary: GOOS (33.65 -29.73%), ANF (17.3 -29.7%), TLYS (7.8 -25.78%), MOV (25.76 -23.04%), NIO (3.05 -20.98%), PVH (85.19 -20.35%), CONN (17.95 -19.61%)
• Information Technology: NTNX (28.07 -20.12%), CAMP (10.16 -19.17%)
• Energy: SDRL (3.94 -28.36%), ROAN (2.09 -20.23%)
• Consumer Staples: DF (1.1 -19.71%)

Veeva Systems (VEEV) reported earnings on Wed 29 May 19 (a/h)

** charts before earnings **

** charts after earnings **

Veeva Systems beats by $0.05, beats on revs; guides JulQ EPS above consensus, revs above consensus; guides FY20 EPS above consensus, revs above consensus

• Reports Q1 (Apr) earnings of $0.50 per share, excluding non-recurring items, $0.05 better than the S&P Capital IQ Consensus of $0.45; revenues rose 25.2% year/year to $244.75 mln vs the $238.69 mln S&P Capital IQ Consensus.
• Co issues upside guidance for Q2 (Jul), sees EPS of $0.48-0.49, excluding non-recurring items, vs. $0.46 S&P Capital IQ Consensus; sees Q2 revs of $259-260 mln vs. $249.7 mln S&P Capital IQ Consensus.
• Co issues upside guidance for FY20, sees EPS of $2.01-2.03, excluding non-recurring items, vs. $1.92 S&P Capital IQ Consensus; sees FY20 revs of $1.045-1.050 bln vs. $1.03 bln S&P Capital IQ Consensus.

Earnings this week : May 27 - 31, 2019 (wk 22)

Monday (May 27)

• Markets closed for Memorial Day

Tuesday (May 28)

• Morning: AMWD BAH BNS MOMO NIO PLAN
• Afternoon: HEI NXGN RAMP WDAY YY

Wednesday (May 29)

• Morning: ANF BMO BZUN CMCO CPRI DAKT DKS GOOS HLNE HMLP THR WUBA
• Afternoon: DSGX KEYS PANW PVH QADA SMTC TLYS UHAL VEEV VRNT

Thursday (May 30)

• Morning: BITA BURL CSIQ DBI DG DLTR EXPR JILL MOV SAFM SPWH TECD TITN
• Afternoon: COO COST DELL GPS MRVL NTNX OKTA RRGB UBER ULTA VMW WSM YEXT ZS ZUO

Friday (May 31) 

• Morning: BIG GCO

• Workday (NASDAQ:WDAY), Momo (NASDAQ:MOMO), Nio (NYSE:NIO) and YY (NASDAQ:YY) on Mon May 28; 
• Palo Alto Networks (NYSE:PANW), Capri Holdings (NYSE:CPRI), Abercrombie & Fitch (NYSE:ANF) and Dick's Sporting Goods (NYSE:DKS) on May 29; 
• Lululemon (NASDAQ:LULU), Dell (NYSE:DELL), Costco (NASDAQ:COST), Gap (NYSE:GPS), Dollar General (NYSE:DG) and VMware (NYSE:VMW) on May 30; 
• Big Lots (NYSE:BIG) and Build-A-Bear Workshop (NYSE:BBW) on Fri May 31.

This week's biggest % winners & losers : Feb 26 - March 2, 18 (wk 9)

The following are this week's top 20 percentage gainers and top 20 percentage losers, categorized by sectors (over $300 mln market cap and 100K average daily volume).

This week's top 20 % gainers

• Healthcare: MGNX (28.94 +23.36%), VEEV (73.77 +19.85%), ONCE (65.67 +19.36%), ACHN (3.51 +18.78%), NKTR (102.87 +14.81%), SGYP (2.17 +14.21%)
• Materials: TAHO (4.91 +23.06%)
• Industrials: STB (7.5 +19.43%)
• Consumer Discretionary: DDS (87.97 +23.33%), ETSY (25.71 +22.02%)
• Information Technology: UBNT (67.4 +18.25%), HLIT (3.45 +16.95%)
• Financials: PHH (10.62 +22.35%), NGHC (23.55 +16.87%)
• Energy: SWN (4.47 +19.52%), TUSK (28.42 +16.48%)
• Telecommunication Services: NIHD (1.28 +24.27%), I (4.76 +20.51%)

This week's top 20 % losers

• Healthcare: AKRX (18.97 -37.02%), PTLA (34.25 -25.25%), ACAD (23.68 -24.87%), PDCO (25.01 -22.47%), VRX (14.88 -20.34%), EGRX (53.63 -19.79%), EXEL (24.08 -18.4%), RDUS (32.92 -18.02%)
• Materials: ALB (95.02 -19.98%), SQM (47.85 -18.05%)
• Industrials: BW (5.53 -20.09%)
• Consumer Discretionary: NTRI (31.45 -24.31%), ODP (2.51 -18.77%)
• Information Technology: BOX (18.82 -19.3%)
• Energy: CRC (14.98 -25.95%), HK (5.35 -23.46%), CRZO (14.9 -19.2%)
• Consumer Staples: MNST (54.16 -17.79%)
• Telecommunication Services: FTR (7.00 -23.08%)

Veeva Systems (VEEV) reported earnings on Tue 27 Feb 2018 (a/h)

** charts 3rd day after earnings **

  

• Cloud computing application Veeva Systems (VEEV) has served exclusively the life sciences industry. 
• The company is now seeing progress expanding beyond the life sciences industry to things such as chemical makers, packaged goods producers, and cosmetics firms.

For the fourth quarter, Veeva reported adjusted income of 23 cents per share on $184.9 million in sales, rising a respective 4.5% and 23% vs. the year-earlier period. Both metrics topped the consensus for adjusted profit of 21 cents a share on $180 million in sales.

Subscription service sales advanced 26% year over year to $150.9 million, Veeva said in a news release. For the first time, Veeva posted double-digit new-customer gains in each area of its Vault products — clinical, quality, regulatory and commercial.

"The combination of strong sales performance in the fourth quarter and momentum in Vault contributed to a healthy raise in our revenue and profit guidance for fiscal 2019," Chief Financial Officer Tim Cabral said in a prepared statement.

For the fiscal year ending Jan. 31, 2019, Veeva said it expects adjusted profit of $1.30-$1.33 a share and $815 million to $820 million in sales. The outlook crushed analyst expectations for adjusted profit of $1.01 per share and $807 million in sales.

VEEV — is it a buy?

• 12/16/16:   Is VEEV a buy?

• The following 15 months (monthly chart):

Veeva Systems (VEEV) reported earnings on Tue 11/22/16 (a/h)

** charts before earnings **

** charts after earnings **

 

Veeva Systems beats by $0.06, beats on revs; guides Q4 EPS above consensus, revs above consensus  :

• Reports Q3 (Oct) earnings of $0.22 per share, excluding non-recurring items, $0.06 better than the Capital IQ Consensus of $0.16; revenues rose 33.6% year/year to $142.8 mln vs the $135.8 mln Capital IQ Consensus.
• Co issues upside guidance for Q4, sees EPS of $0.17, excluding non-recurring items, vs. $0.15 Capital IQ Consensus Estimate; sees Q4 revs of $145-146 mln vs. $140.65 mln Capital IQ Consensus Estimate.
• "Consistently strong demand across product lines drove better than expected revenue and profitability in the third quarter...We continue to execute well against our multi-billion dollar market opportunity and remain slightly ahead of our revenue target for 2020."

Veeva Systems (VEEV) reported earnings Thur 26 May 2016 (a/h)

** charts before earnings **

** charts after earnings **

  

Veeva Systems beats by $0.04, beats on revs; guides Q2 EPS in-line, revs above consensus; guides FY17 EPS in-line, revs above consensus :

• Reports Q1 (Apr) earnings of $0.15 per share, $0.04 better than the Capital IQ Consensus of $0.11; revenues rose 33.3% year/year to $119.8 mln vs the $115.52 mln Capital IQ Consensus.
• Co issues guidance for Q2, sees EPS of $0.13 vs. $0.13 Capital IQ Consensus Estimate; sees Q2 revs of $125.5-$127.0 mln vs. $123.19 mln Capital IQ Consensus Estimate.
• Co issues guidance for FY17, sees EPS of $0.55-$0.57 vs. $0.55 Capital IQ Consensus Estimate; sees FY17 revs of $516-$520 mln vs. $512.21 mln Capital IQ Consensus Estimate.
• Co states, "Cash flow was also a standout in the first quarter, with the addition of more than $100 million to the balance sheet."

Veeva Systems (VEEV) (3/16)

Veeva Systems (VEEV) (12/15)

Veeva Systems (VEEV) reported earnings on Thur 8/28/14 (a/h)

** chart after earnings **

Veeva Systems (NYSE:VEEV), boosted by some big sales, blew past analyst Q2 expectations, and its stock soared to a five-month high.

JPMorgan raised its price target on Veeva stock to 32 from 27 while Canaccord Genuity hiked its target to 33 from 30. Both rate Veeva stock overweight, or buy.

Veeva provides customer relationship management, content management and other software services to the life science industry.

The company continues to capture a share of the $5 billion CRM and content management software market for life sciences, said Brendan Barnicle, an analyst for Pacific Crest Securities, in a report late Thursday. He rates the stock outperform.

"Veeva's billings and subscription revenue accelerated to over 60% year-over-year growth in fiscal Q2, providing strong visibility," he wrote. "The company's large deals also increased."

In its fiscal Q2 ended July 31, Veeva late Thursday reported earnings per share minus items of 9 cents, up 43% from the year-earlier period and 2 cents better than analyst estimates.

Revenue jumped 53% to $75.7 million, where analysts had expected $69 million.

Veeva (VEEV) : 10-month performance

• Q1 earnings Aug 28 (after close)

** daily **

** daily **